Compare
Up to four compounds, side by side.
Search or pick a starting set. Differences light up so you can spot them fast.
Dulaglutide
1 / 4
Peptide
GLP-1 Agonist
DulaglutideOverview
Summary
Weekly GLP-1 with cardiovascular outcome data in T2D.
Category
GLP-1 Agonist
Mechanism
Long-acting GLP-1 fusion protein — weekly dosing.
Effects
Top outcomes
- Fat loss60
Evidence
Established
Practical
Half-life
~5 days
Administration
subq
Risk
Legal status
rx only
Safety
Nausea on titration; well-tolerated long term.
Try a preset